TETRALOGIC PHARMACEUTICALS CORP (OTCMKTS:TLOG) Shorts Decreased by 7.13% After Short Covering

April 16, 2018 - By Stephen Andrade

The stock of TETRALOGIC PHARMACEUTICALS CORP (OTCMKTS:TLOG) registered a decrease of 7.13% in short interest. TLOG’s total short interest was 66,400 shares in April as published by FINRA. Its down 7.13% from 71,500 shares, reported previously. With 107,600 shares average volume, it will take short sellers 1 days to cover their TLOG’s short positions. The short interest to TETRALOGIC PHARMACEUTICALS CORP’s float is 0.45%.

The stock decreased 12.06% or $0.0024 during the last trading session, reaching $0.0175. About 3,338 shares traded. TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG) has 0.00% since April 16, 2017 and is . It has underperformed by 11.55% the S&P500.

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. The company has market cap of $428,139. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. It currently has negative earnings. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.